Skip to content

Marea Therapeutics

CompanyUnited States· Biotech

US clinical-stage cardioendocrine drug developer.

Minutes holds 1 development and 1 deal naming Marea Therapeutics, recorded from September 2026.

Intelligence

Deals in Minutes

Deals naming Marea Therapeutics
CompanyDealAmountCounterpartiesDate ↓Status
Marea TherapeuticsHealthcareAcquisitionNot recordedAcquired by Lisata Therapeutics17 SepClosed
Showing 1–1 of 1

Acquirers in Minutes

Lisata TherapeuticsAcquisition · ClosedSep 17, 2026